Navigation Links
Novadaq Updates on OPTTX Data Reported at Euroretina
Date:5/29/2008

Visual Acuity Reported to Remain Stable or Improve in 83% of Patients

Studied at 12 Months

TORONTO, May 29 /PRNewswire-FirstCall/ - Novadaq(R) Technologies Inc. (TSX: NDQ), a developer of real-time medical imaging and image guidance systems for the operating room, today announced that ophthalmologists from Sacco Hospital in Milan, Italy reported independent 12-month follow-up data on patients treated with the OPTTX(R) System in commercial practice at the recent Euroretina Conference held in Vienna Austria. The 12 month visual acuity (VA) data for those wet-AMD patients followed, some of whom had failed other treatments, continued to support the previously reported six-month data presented at the Association for Research in Vision and Ophthalmology Conference in April 2008 in Fort Lauderdale, FL.

At 12 months, 23 patients were evaluable and the VA for a substantial majority (19, or 83%) of patients studied remained stable or improved. Fourteen of the 23 (61%) had no change or showed a 1-6 line improvement in VA. Five patients lost up to 3 lines and 4 patients lost more than 3 lines in VA. The treating ophthalmologists concluded that the OPTTX technique was safe and reproducible. This study suggests that treatment with OPTTX can be used as an alternative to the anti-VEGF drugs and that it appears that it can be safely applied before, after or in combination with anti-VEGF injections.

"We have been using the OPTTX System in our practice for the past eighteen months. OPTTX has allowed us to stabilize or improve vision in patients, many who had failed previous therapies, and really had no other treatment alternatives," said Giovanni Staurenghi, Professor of Ophthalmology, Chairman Eye Clinic, Director II School of Ophthalmology, Department of Clinical Science Luigi Sacco, Sacco Hospital, University of Milan. "Most importantly, the twelve-month follow-up data demonstrates that the treatment with OPTTX is sustainable."

"I have spent the last five years working with OPTTX and its predecessors for the treatment of wet AMD and have consulted with other ophthalmologists throughout Europe who were learning to use it," noted Dr. Chiara Veronese, Consultant Ophthalmologist. "The past year has been particularly rewarding in that we have followed patients treated with OPTTX in both Milan and in Coventry and have seen benefits from its use."

The OPTTX-2N1 System, using the same core technology as the commercially available SPY(R) System, is a single device that performs multiple functions. The OPTTX System is designed to enable ophthalmologists and those trained in retinal subspecialties to diagnose, treat and provide on-going management of patients suffering from wet AMD. As the only imaging device with the ability to visualize the disease state of wet AMD during treatment, OPTTX allows the ophthalmologist to accurately diagnose and treat by targeting and closing the abnormal feeder vessels in real-time, within a single patient visit. OPTTX also allows for immediate confirmation of the effectiveness of the treatment.

About Novadaq Technologies

Novadaq Technologies Inc. commercializes real-time imaging and image guidance systems for use in the operating room. With one set of proprietary core technologies, Novadaq's products have multiple applications. Novadaq's SPY System enables cardiac surgeons to diagnose intra-operatively by visually assessing coronary vasculature and bypass graft functionality during the course of heart bypass surgery. The SPY System is also indicated for use during other surgeries, such as cardiovascular, plastic, reconstructive, organ transplant and urological procedures. SPY can be used to visualize blood vessels, tumors, tumor margins and the lymphatic system. Novadaq introduced PINPOINT(TM), its first minimally invasive imaging system for autofluorescence in October 2007. PINPOINT allows surgeons to differentiate between healthy and cancerous tissue in the lung and other hollow organs. Further expanding its portfolio of minimally invasive products, Novadaq is developing SPYscope which combines the typical features of a standard endoscope with the additional capabilities of SPY imaging. Novadaq is the exclusive United States distributor of PLC Medical's CO(2) HEART LASER System, used in the same cardiac procedures as the SPY System. Novadaq also offers the OPTTX(R) System, which leverages the company's core imaging technology and is designed for the diagnosis, evaluation and treatment of wet Age-related Macular Degeneration (AMD). For more information, please visit the company's website at http://www.novadaq.com.

Forward looking Statements

Certain statements included in this press release may be considered forward-looking. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on Novadaq's current beliefs as well as assumptions made by and information currently available to Novadaq and relate to, among other things, results of future clinical tests of PINPOINT and the SPY System, anticipated financial performance, business prospects, strategies, regulatory developments, market acceptance and future commitments. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by Novadaq in its public securities filings actual events may differ materially from current expectations. Novadaq disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Novadaq Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Novadaq Resumes Normal Business Operations by Securing ICG for SPY
2. Novadaq launches PINPOINT: Companys first minimally invasive imaging system
3. Novadaq announces third quarter 2007 conference call and webcast
4. Novadaq to present at Piper Jaffray Healthcare Conference
5. Novadaq to present at BMO Healthcare Conference
6. Novadaqs SPY Imaging System named Product of the Year by Frost and Sullivan
7. Novadaqs SPY System receives clearance for use in organ transplant surgery
8. Novadaq Data Presented at 2008 Society of Thoracic Surgeons Meeting
9. NOVADAQs SPY System to be Featured During Live Broadcast of Robotic Surgery
10. Novadaq to present at Cowen Healthcare Conference
11. Novadaq to hold fiscal 2007 year-end and fourth quarter results conference call and webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... LEXINGTON, Ky. (PRWEB) , ... October 13, 2017 , ... ... MD, MPH to become its next President and Chief Executive Officer, succeeding Dr. James ... and CEO Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , which ... evacuation of the facility as part of a disaster drill on October 3rd. , ... and Shelton City Emergency Manager, as well as the Connecticut Long Term Care ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading ... announced that its MyDario product is expected to appear on The Dr. ... The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show ... The segment ...
(Date:9/22/2017)... , Sept. 22, 2017  As the latest ... Senators Bill Cassidy (R-LA) and Lindsey ... notes that the medical device industry is in an ... device tax, the 2.3% excise tax on medical device ... they also want covered patients, increased visits and hospital ...
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , ... Allentown, Penn. , and OptiMed Specialty Pharmacy of ... business partnership to offer a strategic hub service that ... Healthcare,s highly sought-after personal spirometer, Spiro PD 2.0, and ... A spirometer is a medical device used to ...
Breaking Medicine Technology: